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Radioimmunoassay for urinary renal tubular antigen: A
potential marker of tubular injury
RICHARD A. ZAGER and CHARLES B. CARPENTER
Departments of Medicine, Peter Bent Brigham Hospital, Boston, and the West Roxhury Veterans Administration Hospital,
West Roxbnry, Massachusetts
Radioimmunoassay for urinary renal tubular antigen: A poten-
tial marker for tubular injury. A human proximal renal tubular
epithelial antigen (designated HRTE-l) was isolated and purified
from a crude tubular preparation (Fx1A) by a process of salt
fractionation, DEAB anion-exchange chromatography, and Seph-
adex G-200 gel filtration. Utilizing 1251-HRTE-l and a rabbit anti-
serum specific for the proximal tubular brush border, as deter-
mined by immunofluorescent microscopy, a radioimmunoassay by
competitive protein-binding was developed. HRTE-l was demon-
strated in serum and urine and in extracts of a variety of body
organs. A range of concentrations for normal random urine sam-
ples and 24-hr urine excretion rates were determined. Random
urine samples from 36 patients with a variety of functional and
pathologic renal disorders were assayed for the HRTE- 1 antigen.
Twenty-three of 24 patients with either chronic nephropathy or
pre-renal azotemia had normal urinary antigen concentrations,
despite wide differences in urine flow rates, the degree of existing
renal function, and the amount of proteinuria. Ten of 12 patients
with acute tubular necrosis, however, had statisticaily abnormal
HRTE-t concentrations (high in eight patients, undetectable in
two). These findings suggest that HRTE-l antigen can be detected
in both normal and pathologic urines, that altered antigen concen-
trations can be documented in at least one renal disorder, and that
quantitation of HRTE-l in urine may have clinical value as a
marker of acute tubular injury.
Dosage radio-immunologique de l'antigène tubulaire renal dans
l'urine. Un antigéne de l'épithélium du tube proximal du rein
humain (HRTE- 1) a été isolé et purifié a partir d'une preparation
tubulaire grossiére (Fx1A) par un procédé de fractionnement par
des solutions salines, une chromatographie d'échange anionique
sur DEAE et une filtration sur gel de Sephadex G-200. Un dosage
radio-immunologique a été mis au point au moyen de HRTE-l
marqué par 125J et d'un anti-serum de lapin spécifique de Ia bor-
dure en brosse du tube proximal, ainsi qu'en témoigne la micros-
copie en immunofluorescence. La presence d'HRTE-l a été mise
en evidence dans le serum, l'urine et divers organes. L'éventail
des concentrations et des excretions de 24 hr dans les urines
normales recueillies au hasard a été déterminé. Les urines recueil-
lies au hasard chez 36 malades atteints de divers désordres rénaux
fonctionnels ou organiques ont été étudiées en ce qui concerne
HRTE-l. Vingt-trois parmi les 24 malades atteints soit de nephro-
pathie chronique soit d'hyperazotemie pré-renale avaient des con-
centrations urinaires d'antigéne normales malgré des differences
importantes de debit urinaire, de fonction renale résiduelle et de
protéinurie. Cependant dix parmi douze malades atteints de née-
rose tubulaire aigue avaient des concentrations significativement
anormales de HRTE-l (élevées chez huit et indétectables chez
duex d'entre eux). Ces constatations suggérent que l'antigéne
HRTE-1 peut être détecté aussi bien dans les urines normales que
pathologiques, que les anomalies des concentrations d'antigène
peuvent étre observées au moms dans une affection rénale et que
Ia quantification de HRTE-l dans I'urine peut avoir un intérét
clinique comme indice d'une lesion tubulaire aiguë.
The urinary exretion of renal antigens has been
documented in both experimental animals and man.
McPhaul and Dixon [11 demonstrated glomerular
basement membrane-like antigens in normal human
urine by immunodiffusion. Antoine and Nevue [21,
studying pathologic human urine by immunoprecipi-
tation, reported finding poorly characterized tissue
antigens in urine samples of patients with acute tubu-
lar necrosis, hypokalemic nephropathy, and acute
glomerulonephritis. Rosenmann et a! [31 demon-
strated kidney-specific antigens in urine samples of
rats with a vairety of toxic nephropathies. Using
immunodiffusion, Schoenfeld and Glassock [4] iden-
tified a proximal tubular brush border epithelial anti-
gen (designated URTE) in 100-fold concentrated nor-
mal human urine. Miyakawa et a! [51 reported
finding a similar tubular antigen (Tub-Ag) in concen-
trated urine by radioimmunoassay.
In view of these reports of renal antigen excretion
in both normal and pathologic urine, it seemed possi-
ble that a technique to quantitate the excretion of a
single proximal tubular antigen might have clinical
relevance. This paper describes the development of a
radioimmunoassay capable of detecting and quanti-
tating a single human renal tubular epithelial antigen
(designated HRTE-l) in unconcentrated urine and
serum. Data are presented which suggest that an
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abnormal urinary antigen concentration may be a
marker of acute tubular insult.
Methods
Renal tubular epithelial fractions. A crude tubular
fraction was prepared from normal human kidneys
by pressing cortex through a 115-mesh stainless steel
sieve. The mash was suspended in six volumes of
phosphate-buffered normal saline (PBS; pH, 7.5),
and centrifuged repetitively at 400g for 10 mm until
no further sediment was obtained. The supernatant
(Fxl) was saved and centrifuged at 80,000g for 45
mm. The resultant supernatant (Fx1B) was lyophi-
lized. The sediment (Fx1A) was washed five times
with PBS and three times with distilled water, recen-
trifuging each time at 80,000g for 45 mm, and then
lyophilized.
Antiserum to renal tubular antigens. Adult, male,
New Zealand white rabbits were injected approxi-
mately every 10 days over a five-month period with
15 mg of lyophilized Fx1A emulsified in incomplete
Freund's adjuvant and normal saline. Initial injec-
tions were given in the rear foot pads, and subse-
quent injections were given at rotating intradermal
sites. The rabbits were periodically bled, one week
following the previous immunization. Antisera were
absorbed four times, either with lyophilized normal
human serum (NHS), 3 mg/ml of antiserum, or on
some occasions with 3 mg of NHS plus 3 mg of
Fx1B/ml of antiserum. Absorptions were carried out
for two hours each, one hour at 22°C and one hour at
40 C. After each absorption, antisera were centri-
fuged at 1300g for 15 mm. After the final absorption,
the antisera were centrifuged at 105,000g for one
hour. In addition, some antiserum was absorbed
overnight at 4° C with NHS, polymenzed with glu-
taraldehyde [61.
Immunofluorescent staining methods. Sections of
human kidney were snap-frozen in isopentane, at
—20° C, and 6-j.. sections were prepared. Indirect
immunofluorescence, using anti-Fx lA antiserum ab-
sorbed with NHS/Fx1B, was performed according to
the technique of Coons, Leduc, and Connelly [71 to
localize intrarenal sites of antiserum reactivity. Con-
trols included PBS, non-immune rabbit serum, and
antiserum absorbed two times with Fx1A, solubi-
lized as below (4 mg/mi of antiserum). The antisera
were diluted 1:8 in PBS prior to use.
Immunologic analysis o.f antigens. Human renal
tubular epithelial antigens (HRTE) were identified
during isolation techniques by immunodiffusion in
1% agarose, and by immunoelectrophoresis in 1%
agarose in barbital buffer (pH, 8.6). Anti-Fx1A anti-
serum, absorbed with NHS/Fx1B, was used for both
immunodiffusion and immunoelectrophoresis. Pre-
cipitin reactions were allowed to develop for two to
seven days.
Solubilization of HRTE antigens. The HRTE anti-
gens were solubilized from Fx1A using 1% sodium
deoxycholate, 1 ml per 20 mg of Fx1A, for three
hours at 4° C, according to the method of Edgington
et al [81. The supernatant containing the HRTE anti-
gens was brought to 25% ammonium sulfate satura-
tion, and the reaction was kept at a constant stir for
12 hr at 4° C. The supernatant (crude HRTE) was
saved, extensively dialyzed against PBS, concen-
trated by negative pressure dialysis to a concentra-
tion of 2 mg/mi, and stored at —20° C.
Protein determinations. Protein concentrations
were determined by the method of Folin [9] or esti-
mated by absorbance at 280 nm using bovine serum
albumin standards.
DEAE cellulose chromatography. DEAE cellulose
was equilibrated with 0.0175 M sodium phosphate
(pH, 6.5) and packed to a height of 25 cm in a 1.5-cm
diameter column. Fifteen miffihiters of the crude
HRTE solution (from Fx1A) was further concen-
trated (five times), dialyzed overnight against the
starting buffer, and applied to the column. A salt
gradient was formed for elution of HRTE antigens,
using a 100-ml mixing beaker with starting buffer and
a 100-mi reservoir beaker containing 1.8 M sodium
chloride and 0.0175 M sodium phosphate (pH, 6.5).
The column was washed with 50 ml of starting
buffer, and then elution was begun. Two-milliliter
fractions were collected, selectively pooled, concen-
trated to 1 ml by negative pressure dialysis, and
assayed for HRTE antigens by immunodiffusion.
The first HRTE antigen eluted off the DEAE column
was designated HRTE-1. (This terminology bears no
relationship to that used for tubular antigens isolated
from rat kidney [81.)
Gel filtration on Sephadex G200. DEAE cellulose
elution fractions containing HRTE- 1 were concen-
trated to 0.2 ml by osmotic equilibration with flakes
of polyethylene glycol (mol wt, 20,000 daltons). The
sample was then dialyzed against PBS and applied to
a 1.5-cm column packed to a height of 25 cm with
Sephadex G-200 equilibrated with PBS. One-hall-
milliliter fractions were collected and assayed for
HRTE- 1 by immunodiffusion. Fractions containing
HRTE-1 were pooled, concentrated to a protein con-
centration of 4.5 mg/mi, and subjected to immuno-
electrophoresis using unabsorbed anti-Fx1A anti-
serum and goat anti-NHS antiserum (Arnel
Products, Brooklyn, N.Y.).
Radioimmunoassay (RIA) of HRTE-1. HRTE-1
was radiolabelled with 125J by the chloramine-T
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method [101. Separation of iodinated protein from
unreacted iodide and low molecular weight reactants
was achieved by gel filtration on a 1.5-cm x 25-cm
Sephadex G-200 column, and 0.5-mi fractions were
collected. Radiolabelled protein, recovered in the
first half of the exclusion peak, was pooled, dialyzed
against RIA buffer (0.02 M Tris, 0.13 M sodium chlo-
ride, 0.01 M EDTA, 0.05% sodium azide, 0.20%
bovine serum albumin; pH, 7.8), diluted to an
HRTE- I concentration of 0.50 jsg/ml in RIA buffer,
and then stored at —20° C.
The assay was performed by adding to sterilized
polyethylene tubes: 0.1 ml of RIA buffer, 0.1 ml of a
1:2000 dilution of rabbit anti-Fx1A antiserum ab-
sorbed with NHS, and 0.1 ml of the test sample. The
reaction was allowed to incubate at 4° C for one
hour. Then 0.1 ml of buffer containing 50 ng of 125J
HRTE-1 plus 1 sl of normal rabbit serum was added.
The reaction was incubated for 18 hr at 4° C, and
then 0.1 ml of a 1:6 dilution of sheep anti-rabbit
antiserum (Arnel Products, Brooklyn, N.Y.) was
added. The reaction was again incubated for 18 hr at
4° C. Finally, I ml of RIA buffer was added, the
tubes were centrifuged at I ,300g for 45 mm at 4° C,
and the supernatant was decanted. All tubes were
counted in a gamma counter, and the percent of
precipitation was determined. For each assay, a
complete standard curve was constructed, using 0.1
ml of known standards instead of test samples. A
total of 14 standards were used, consisting of two-
fold serial dilutions of either purified HRTE- 1 or its
crude HRTE immunoreactive equivalent, and the
results were plotted on semilogarithm paper.
Clinical samples. Ten serum samples, 36 random
urine samples, twelve two-hour urine samples, and
seven 24-hr urine collections were obtained from
normal subjects. Additional serum samples were ob-
tained from two anephric patients who were being
maintained on hemodialysis. Fourteen spot urine
samples obtained from patients with known nephrol-
ogic diagnoses, and a 24-hr urine from a patient with
nephrotic syndrome (creatinine, 4.0; 24-hr protein
excretion, 4.5 g) were also collected. Additional ur-
ine samples were obtained from 22 consecutive pa-
tients with acute renal insufficiency, diagnosed by a
rapidly rising serum creatinine within a one-week
time frame. All urines were centrifuged at 1,300g for
five minutes. The sediments were discarded, and 1
ml of each supernatant was dialyzed against PBS
prior to assay. A 1-nil sample of NHS was dialyzed
against PBS and then fractionated into l9S, 7S, and
4S peaks on a 2.5-cm x 90-cm Sephadex G200 col-
umn equilibrated with PBS. A sample of a Sephadex
G-200 19S peak of 100-fold concentrated normal hu-
man urine (known to contain URTE [4]) was used
for anti-FxlA antibody absorption studies.
Ten-gram samples of liver, small intestine, stom-
ach, lung, adrenal, thyroid, and testis were obtained
from a patient dying of an acute myocardial infarc-
tion. They were homogenized with PBS in a Sorvall
blender. Then they were centrifuged, washed, solu-
bilized with sodium deoxycholate, fractionated with
ammonium sulfate and dialyzed in an identical fash-
ion as that described for kidney FxlA. The extracts
were then assayed for HRTE-1.
Results
Rabbit antiserum to tubular antigens (anti-FxJA).
By immunofluorescent microscopy, the anti-FxlA
antisera absorbed either with NHS, or NHS/Fx1B,
stained exclusively the luminal surface of the proxi-
mal tubule in the region of the brush border (Fig. 1).
Immunofluorescence was inhibited by prior absorp-
tion of anti-FxlA antiserum with solubilized Fx1A.
The normal rabbit serum and PBS controls were
negative.
Both NHS-absorbed and NHS/Fxl B-absorbed
antisera identified two major renal tubular epithelial
antigens in solubilized Fx1A (designated HRTE-l
and HRTE-2). A third antigen, HRTE-3, was sug-
gested by a faint precipitin line on immunodiffusion
which could not be detected by immunoelectropho-
resis. Antiserum absorbed only with NHS did not
recognize any unique HRTE antigens in FxlB, al-
though faint precipitin lines identical with HRTE-1
and HRTE-2 were identified.
Isolation of HRTE-1. Approximately 750 mg of
lyophilized Fx1A could be extracted from each
whole kidney that was subjected to cortical dissec-
tion, sieving, and differential centrifugation. Approx-
imately 50% of the Fx1A could be solubilized with
1% sodium deoxycholate, the HRTE antigens being
recovered in the supernatant. Twenty-five percent of
ammonium sulfate salt fractionation resulted in pre-
cipitation of approximately 65% of the solubilized
Fx1A. Both HRTE-1 and HRTE-2 were again re-
covered in the supernatant, but HRTE-3 could no
longer be detected in the soluble phase.
Separation of HRTE-l and HRTE-2 was achieved
by anion exchange chromatography on DEAE cellu-
lose (Fig. 2a). HRTE-l was recovered at a conduc-
tance of 4.3 millimhos, corresponding to the leading
limb of the second major protein peak. HRTE-2 was
eluted immediately after HRTE- 1.
The isolated HRTE-1 was further purified by
Sephadex G-200 gel filtration, the antigen being re-
covered in the excluded peak (Fig. 2b). The final
recovery of HRTE- 1 represented approximately
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Fig. 1. Immunofluorescentmicroscopy demonstrating fixation of anti-FxIA antiserum (absorbed with NHS/FxIB) to the brush border of the
proximal tubular epithelium (magnification, X640).
1.0% of the starting Fx1A. To assess immunologic
purity, immunoelectrophoresis and immunodiffus ion
were performed, using purified HRTE-1 at a concen-
tration of 4.6 mg/ml, and run against both unab-
sorbed anti-FxIA antiserum and goat anti-NHS anti-
serum. A single precipitin line developed with
unabsorbed anti-Fx1A antiserum (Fig. 3). Goat anti-
NHS antiserum produced no precipitin line.
Establishment of HRTE-] radioimmunoassay. 1)
Radiolabeling of HRTE-1. After radiolabeling with
12J HRTE-1 was recovered in the Sephadex G-200
exclusion peak. The HRTE-1 recovered in the lead-
ing limb of this peak was chosen for use in the
radioimmunoas say. After dialysis, 90% of the radio-
activity was 10% trichloroacetic acid precipitable. A
specific activity of 100 MCi/mg was achieved.
2) Antiserum titration curves. Although purified
HRTE-1 was shown by immunodiffusion and immu-
noelectrophoresis to be free of serum protein con-
taminants, we elected to use antiserum absorbed
with NHS to further insure specificity of the assay.
Because NHS-absorbed anti-Fx1A antiserum did not
identify any unique Fx1B antigens by immunodiffu-
sion and immunoelectrophoresis, and because Fx1B
was shown to contain some HRTE- 1, the antiserum
used for the RIA was not absorbed with Fx1B. Anti-
serum titration curves using two-fold serial antisera
dilutions were run. Dilutions of 1:20 of either unab-
sorbed anti-Fx1A or NHS-absorbed anti-Fxla anti-
sera resulted in maximum precipitation of 125J
HRTE-1 (50 ng) of 82% and 78%, respectively. A
1:2000 dilution of NHS-absorbed anti-Fx1A anti-
serum precipitated 52% of 125J HRTE-1, and this
dilution of NHS-absorbed antiserum was used for all
subsequent assays. Non-specific precipitation was
between 14% and 15%.
3) Standard curves. Identical standard curves
were produced using serial dilutions of either purified
HRTE-1 or eight times as much crude HRTE (Fig.
4). Subsequent standard curves were run with crude
HRTE standard dilutions because of their greater
apparent stability with time. Unknown clinical sam-
ples were read from the standard curve in terms of
pure HRTE-1 concentrations.
4) RIA antibody absorption studies. Precipitation
of 1251-HRTE-1 by antiserum was completely inhib-
'V
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Fig. 2. a) Separation of HRTE-1 from HRTE-2 and from other
uncharacterized proteins on DEAE cellulose; b) Sephadex G-200
gel filtration of DEAE fractions containing HRTE-1. HRTE-1
was recovered in the excluded protein peak.
ited by prior incubation of antiserum (0.1 ml of a
1:2000 dilution) with 50 g of purified HRTE-1, or
400 tg of crude HRTE, or 0.1 ml of the 100-fold
concentrated 19S Sephadex G-200 peak of pooled
normal human urine. The same quantity of antiserum
absorbed with progressively increasing amounts of
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Fig. 4. Radioimmunoassay standard curve using two-fold serial
dilutions of purified HR TE-1 , 0.1 ml of 1:2 000 dilutionof anti-FxJA
antiserum, absorbed with NHS, and 50 ng of 1251-HRTE-1.
Fig. 3. Immunoelectrophoresis of HRTE-1, developed with unabsorbed anti-FxIA antiserum. F.lectrophoresis was carried out at 1.5 volume!
cm for 45 mm. A single precipitin line developed. Anode to left: Photographic artifact appears in central well.
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NHS (0.05 ml to 2.0 ml) resulted in progressive
inhibition of '251-HRTE- 1 precipitation. It was subse-
quently established that HRTE- 1, or a cross-reacting
antigen, is present in serum at a concentration of
approximately 3 pg/mI.
HRTE-1 detection in serum, urine, and organs.
HRTE-l was detected in each of 10 serum samples
obtained from normal subjects. The average concen-
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tration was 2.9 g/m1 (range, 1.9 to 3.4 gIm1).
HRTE-l was also detected at concentrations of 2.9
pg/ml and 3.3 g/ml in sera from two anephric pa-
tients who were on chronic hemodialysis. Serum
antigen was not precipitated by 25%ammonium sul-
fate and was not denatured by heating the sera to 560
C for 30 mm. The Sephadex G-200 19S, 7S, and 4S
fractions of NHS were assayed, and approximately
75% of HRTE-1 was present in the 7S peak, with the
remainder being present in the 19S peak.
Unconcentrated random urine samples from 36
normal subjects revealed a range of HRTE-1 concen-
trations of 0.2 to 1.1 g!ml, (mean, 0.56 g!ml; 95%
confidence limit; 0.1 to 1.0 gIml). The antigen con-
centrations did not correlate with either urinary os-
molality or with urine flow rates, as determined by
the series of twelve two-hour urine collections
(range, 60 to 206 ml per two hours). To correct for
any possible effect of varying urinary osmolality on
the assay itself, however, samples were dialyzed
against PBS prior to assay. Seven 24-hr urine collec-
tions from normal subjects showed an average
HRTE-1 excretion of 466 g per 24 hr, with a range
of 230 to 670 gI24-hr. The 24-hr HRTE-1 excretion
from the patient with nephrotic syndrome was 412
As with serum antigen, urinary antigen was not
precipitated by 25% ammonium sulfate and was not
denatured by heating urine to 56° C for 30 mm.
Solubilized Fx1A organ preparations were assayed
for the presence of HRTE-l activity. The amount of
antigen in the Fx1A of each organ was compared to
the HRTE-l present in an equal weight of renal
cortical Fx1A obtained from the same patient and
expressed as a percent. The highest concentrations
were found in liver (6%), small intestine (2%), and
adrenal tissue (2%), followed by stomach (1%) and
testis (1%). Lung and thyroid tissue samples had
trace amounts (0.03%).
Assay of pathologic urine samples. Assays were
conducted on spot urine samples from 14 patients
with a variety of renal disorders (Fig. 5). Eight pa-
tients had the nephrotic syndrome with 24-hr protein
excretions ranging from 3 to 8 g/24 hr. Diagnoses
included membranous glomerulopathy (three pa-
tients), diabetic glomeruloscierosis (one patient), lu-
pus nephritis (one patient), and unclassified histology
(three patients). Six patients had forms of chronic
tubulointerstitial nephritis including chronic pyelone-
phritis (two patients), nephrosclerosis (two patients),
and hydronephrosis (two patients). Antigen concen-
trations were within the 95% confidence limits (0.1 to
1.0 gIml) for seven of eight patients with the ne-
phrotic syndrome, while one nephrotic patient had a
borderline elevation (1.1 g/ml). Normal antigen
concentrations were found in all six patients with
chronic tubulointerstitial diseases.
To assess the possible usefulness of this assay as a
marker of acute tubular injury, the first available
urine samples from 22 consecutive patients who
were being seen for acute renal insufficiency (less
than one week's duration) were collected. Diagnoses
of either acute tubular necrosis (ATN) or pre-renal
azotemia were established on the basis of the urinary
sediment, spot urine sodium concentration, clinical
setting, course, and eventual clinical outcome. Ten
patients were judged to have pre-renal azotemia
(eight oliguric, <500 ml!24 hr; and two non-oliguric,
>800 ml124 hr). All had normal spot urine HRTE-1
concentrations. Twelve patients were diagnosed as
having ATN (10 oliguric, two non-oliguric). Statisti-
cally abnormal urinary HRTE-1 concentrations (out-
side of the 95% confidence limits) were documented
in 10 of 12 of these patients. High values (1.9 to >50
g/m1) were found in eight patients. Two patients
had undetectable (<6 ng!ml) antigen concentrations,
and two patients had normal antigen concentrations
(Fig. 5).
Two patients with ATN were followed with serial
urine assays until death or clinical recovery (Fig. 6).
Patient no.1 developed oliguric ATN in the setting of
hemorrhagic pancreatitis with shock. Each of three
urine samples obtained from this patient, on different
days of his clinical course, had high urine antigen
concentrations. Patient no. 2 developed ATN sec-
ondary to alcoholic rhabdomyolysis. Five urine sam-
ples were obtained during his disease course, which
included an oliguric and a non-oliguric phase. The
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Fig. 5. Spot HRTE-] concentrations in normal and pathologic
human urine samples. The shaded area represents the 95% confi-
dence limits for normal random urines (0.1 to 1.0 ogIm1).
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Fig. 6. Spot HRTE-1 concentrations in sequential urines from two
patients with acute tubular necrosis. Shaded area represents the
confidence limits for normal random urines (0.1 to 1.0 gIm1).
first four urine samples (days 3,. 5, 7, 9) had high
antigen concentrations, while the fifth urine sample
(day 13) had a normal antigen concentration. This
sample coincided with early recovery of renal func-
tion, as demonstrated by the first spontaneous fall in
his serum creatinine concentration.
Discussion
It has been demonstrated both in experimental
models and in man that one possible response to
tubular injury is loss of proximal tubular brush bor-
der microvilli into urine [11—13]. Schoenfeld and
Glassock 14] were the first to confirm that an antigen
derived from the proximal tubular brush border
could, in fact, be demonstrated in concentrated ur-
ine. They suggested that a technique which could
quantitate renal tubular antigen excretion might be a
useful marker of tubular injury. It is unclear whether
the radioimmunoas say of Miyakowa et a! [51 is suita-
ble for this purpose. The antiserum used in this assay
was not absorbed with normal human serum, and a
direct correlation was noted between the degree of
proteinuria and "Tub-Ag" excretion. Thus, it seems
possible that a serum protein, rather than a kidney-
derived tubular antigen, may have been detected in
this assay system. Furthermore, urine samples had
to be concentrated prior to assay.
The radioimmunoassay for HRTE-1 does appear
to be a useful technique for quantitating renal tubular
antigen excretion in unconcentrated normal and
pathologic urine samples. In its present form, the
assay can detect antigen over a wide range of con-
centrations (6 ng to 50 gIml). A high degree of
reproducibility has been noted. All urine samples
have been assayed in duplicate, and nearly identical
results have been obtained. Furthermore, standard
amounts of antigen have yielded reproducible results
when assayed on different occasions.
The detection of HRTE- I-like material in multiple
body organs and in sera of anephric patients empha-
sizes that this antigen is not entirely kidney-specific.
The assay, however, still appears to have potential
usefulness as a marker of tubular injury. This is
because urinary antigen seems to be largely derived
from the proximal tubule per Se, rather than repre-
senting possible filtered serum antigen. This is sup-
ported by the demonstration of normal urine antigen
concentrations in seven of eight patients with the
nephrotic syndrome. Furthermore, non-renal paren-
chymal injury has not affected urinary antigen con-
centrations in six of our pre-renal patients (Fig. 5).
Two of these patients had acute myocardial infarc-
tion, one had alcoholic hepatitis, one had massive
small intestinal infarction with peritonitis and pan-
creatitis, one had congestive hepatopathy, and one
had bacterial pneumonia. Nevertheless, these pa-
tients all had normal urinary antigen concentrations.
Furthermore, patient no. 2 (Fig. 6) still had active
rhabdomyolysis (CPK, >5000) on day 13 of his clini-
cal course, the day on which he developed a normal
urine HRTE- 1 concentration.
The assay of urine samples from 12 patients with
ATN indicate that abnormal concentrations of tubu-
lar antigen can be documented in at least one ne-
phrologic disorder. As expected, high antigen con-
centrations were detected in the majority of ATN
patients. The finding of high urine antigen concentra-
tions in sequential urine samples from two of these
patients emphasizes that this is not a sporadic phe-
nomenon. Furthermore, the demonstration of nor-
mal antigen concentrations in eight oliguric patients
with pre-renal failure illustrates that elevated antigen
concentrations do not merely reflect low urine flow
rates.
Surprisingly, two patients with oliguric ATN had
undetectable antigen concentrations (<6 nglml, out-
side the 95% confidence limits). To date, approxi-
mately 100 normal and pathologic urine samples
have been assayed. No other urine sample to date
has had an antigen concentration of less than 150 ng/
ml. Therefore, it is difficult to dismiss this finding of
undetectable antigen concentrations in two patients,
both with ATN. We have no clear explanation for
this finding. The clinical courses of these two pa-
tients had no unique clinical features. One might
speculate, however, that a high degree of tubular
o Non-oliguric
(>800mI/24 hr)
• • Oliguric
1< 500 mi!24 hr)
———Pt.tl5.0 - .
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• Death
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obstruction may have been present at the time of
urine assay, resulting in decreased urinary antigen
excretion.
Whether HRTE-l is better suited as a marker of
tubular injury than other renal tubular antigens de-
tected in this study (HRTE-2,3) is unknown. HRTE-
1 was chosen for assay primarily because of its rela-
tive ease of isolation from other tubular elements.
Measurement of URTE (proximal tubular brush bor-
der epithelial antigen), described by Schoenfeld and
Glassock, might also have potential value. It is quite
possible, however, that URTE, recovered from ur-
ine, and HRTE-l, isolated from kidney, might be
identical. Unfortunately, we have no definitive infor-
mation in this regard.
Conclusion. We believe that the radioimmunoas-
say for HRTE-l represents the first technique allow-
ing quantitation of renal tubular antigen excretion in
unconcentrated normal and pathologic urine. The
detection of substantial elevations of a proximal tu-
bular antigen in urine samples from patients with
acute tubular necrosis represents clinical corrobora-
tion of pathologic evidence of loss of brush border
elements in acute tubular injury [11—13]. Further-
more, our present data suggest that measurement of
urinary HRTE- 1 concentrations may have potential
clinical relevance, both as a marker of acute, severe
tubular injury, and possibly as a clinical tool for
differentiating ATN from functional (pre-renal) kid-
ney failure. A large, blind, prospective study, how-
ever, is clearly needed before any firm conclusions
can be reached about this assay's ultimate clinical
utility.
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